October 1, 2018 / 11:19 PM / 7 months ago

Allergan's Forest fights reviving off-label marketing lawsuit

A lawyer for Allergan PLC’s Forest Laboratories faced tough questioning on Monday while trying to preserve the dismissal of a lawsuit claiming it misled the public about the effectiveness of its antidepressants Celexa and Lexapro in treating children.

But at oral argument, a union health insurance fund leading the proposed class action urged a three-judge panel of the 1st U.S. Circuit Court of Appeals in Boston to reverse a ruling from a lower court judge that it could not establish a recognized injury under federal racketeering law.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2Ix0Xvs

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below